Clinical DNA Analysis Using Next-Generation Sequencing - Future of Genomics

The next generation sequencing is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics.

Download PDF Brochure of Study, Click Here @ https://www.theinsightpartners.com/sample/TIPRE00002934/?utm_source=opr%2F10291

The DNA Next Generation Sequencing Market Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Beijing Genomics Institute, Perkinelmer, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Oxford Nanopore Technologies, and Macrogen, Inc. among others.

Next-generation sequencing (NGS), also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA samples. NGS is driving discovery and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. Key factors driving the growth of DNA next generation sequencing market are, increase in cancer prevalence, rise in funds and grants, focus of industry players and various meetings, conferences, workshops The report would be of an interest to various stakeholders operating in the DNA next generation sequencing.

DNA next generation sequencing market is segmented as product, application and end user. On the basis of product, the market is segmented as, platforms, services and consumables. The segment of platform is further classified as, Hiseq series, Miseq series, solid, ion torrent, Pacbio RS ii and sequel systems, and other platforms. The services segment us further categorized as, sequencing services and data management & analysis Services. Also, the segment of consumables is segmented as, sample preparation consumables and other NGS consumables. Based on application, the market is segmented as, diagnostics, drug discovery, precision medicine, and other applications.

The DNA next generation sequencing market based on end user is segmented as, academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and other end users.

Industry Insights of Next Generation Sequencing:

Declining Price of Sequencing:

In recent years, the next generation sequencing price has declined substantially. For instance, the first whole human genome sequencing cost above US$3.7 billion in 2000 and took 13 years for fulfillment. However, the costs for the same in recent years have reduced to US$ 1,000, and the process needs fewer days. In 2000, the price for sequencing was US$ 3.7 billion, which fell to US$ 10 million in 2006 and reduced to US$ 5,000 in 2012. Significant companies such as Illumina and Roche have launched advanced technologies that have allowed in the cost and time reduction in the sequencing. Owing to factors such as advancement in the field of genomics, development in different methods and strategies for sequencing, a notable decline in the cost of sequencing.

Product Insights

The next generation sequencing market based on product is segmented into consumables, services, and platforms. In 2017, the consumables segment held the most significant market share of the next generation sequencing, by product. The segment is further anticipated to command the market in 2025 by product as the consumers widely accept the consumables offered by various companies, and it provides accuracy and precision in the preparation of the NGS. Moreover, the consumers segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Technology Insights

The next generation sequencing market on the basis of technology is segmented into genome sequencing, exome sequencing, resequencing & targeted sequencing and others. In 2017, the resequencing & targeted sequencing segment held a largest market share of the next generation sequencing market, by technology. Furthermore, the resequencing & targeted sequencing segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

The DNA next generation sequencing is expected to grow significantly due to factors such as, declining price of sequencing, technological advancements in sequencing and increasing prevalence of cancer. In addition, usage of NSG in biomarker discovery & precision medicine is anticipated to have a positive impact on the growth of the DNA next generation sequencing market in the coming years.

Regional Outlook for Next Generation Sequencing:

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.

Want to Know More about DNA Next Generation Sequencing...?

Get More Information with PDF Sample Copy @ https://www.theinsightpartners.com/buy/TIPRE00002934/?utm_source=opr%2F10291

Contact Us

Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.